Optimizing Care in Lung Cancer: Current and Emerging Biomarkers for Immuno-Oncology

View an on-demand Webcast of a live CCO Webinar and then download the slides to gain expert perspectives from a medical oncologist and radiation oncologist on personalized IO therapy for patients with lung cancer including discussion of the latest clinical data when to use IO biomarker testing and the intersection of radiation therapy and IO-based therapy in lung cancer.

Share

Program Content

Activities

IO in Lung Cancer
Immunotherapy in Lung Cancer: The Role of IO Biomarkers in Treatment Choice
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2020

Expires: October 22, 2021

IO in Early Stage NSCLC
Immunotherapy for Early Stage NSCLC: On the Horizon
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2020

Expires: October 22, 2021

<i>EP</i>: Biomarkers for Immuno-Oncology in Lung Cancer
ExpressPoints Optimizing Care in Lung Cancer: Current and Emerging Biomarkers for Immuno-Oncology
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2020

Expires: October 28, 2021

Activities

IO Biomarkers for Lung Ca
Optimizing Care in Lung Cancer: Current and Emerging Biomarkers for Immuno-Oncology
Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Jamie E. Chaft, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Kristin Higgins, MD

Medical Director
Associate Professor

Department of Radiation Oncology
Emory University
Atlanta, Georgia

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.